Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × elacestrant × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Endometrial Stromal 1 Recurrence 1 Perivascular Epithelioid Cell Neoplasms 1 Endometrial Neoplasms 1 ER+ Breast Cancer 1 Carcinoma, Intraductal, Noninfiltrating 1 Advanced Breast Cancer 1 Adenosarcoma of the uterus 1

Interventions

trastuzumab deruxtecan 1 elacestrant 1 Letrozole 1 Anastrozole 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06638307 2026-03-11

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Stemline Therapeutics, Inc.

Phase 1 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡